New WHO Guidelines on GLP-1 Therapies for Obesity
December 3, 2025
The World Health Organization has issued new guidelines for the use of GLP-1 therapies in addressing obesity. The guidelines pertain to three substances found in six medications that were initially designed for diabetes. This announcement is critical, as obesity affects over a billion people worldwide, with more cases expected in the future. The approach to treating obesity requires a comprehensive strategy that includes healthy eating and physical activity. The WHO emphasizes that medications alone are not sufficient to tackle the issue.